Literature DB >> 8608939

Repression and activation by multiprotein complexes that alter chromatin structure.

R E Kingston1, C A Bunker, A N Imbalzano.   

Abstract

Recent studies have provided strong evidence that macromolecular complexes are used in the cell to remodel chromatin structure during activation and to create an inaccessible structure during repression, Although there is not yet any rigorous demonstration that modification of chromatin structure plays a direct, causal role in either activation or repression, there is sufficient smoke to indicate the presence of a blazing inferno nearby. It is clear that complexes that remodel chromatin are tractable in vitro; hopefully this will allow the establishment of systems that provide a direct analysis of the role that remodeling might play in activation. These studies indicate that establishment of functional systems to corroborate the elegant genetic studies on repression might also be tractable. As the mechanistic effects of these complexes are sorted out, it will become important to understand how the complexes are regulated. In many of the instances discussed above, the genes whose products make up these complexes were identified in genetic screens for effects on developmental processes. This implies a regulation of the activity of these complexes in response to developmental cues and further implies that the work to fully understand these complexes will occupy a generation of scientists.

Mesh:

Substances:

Year:  1996        PMID: 8608939     DOI: 10.1101/gad.10.8.905

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  167 in total

1.  The human SWI-SNF complex protein p270 is an ARID family member with non-sequence-specific DNA binding activity.

Authors:  P B Dallas; S Pacchione; D Wilsker; V Bowrin; R Kobayashi; E Moran
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  The protein encoded by the proto-oncogene DEK changes the topology of chromatin and reduces the efficiency of DNA replication in a chromatin-specific manner.

Authors:  V Alexiadis; T Waldmann; J Andersen; M Mann; R Knippers; C Gruss
Journal:  Genes Dev       Date:  2000-06-01       Impact factor: 11.361

3.  Targeting a SWI/SNF-related chromatin remodeling complex to the beta-globin promoter in erythroid cells.

Authors:  C H Lee; M R Murphy; J S Lee; J H Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

4.  Periodical distribution of transcription factor sites in promoter regions and connection with chromatin structure.

Authors:  I Ioshikhes; E N Trifonov; M Q Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

5.  The GATA factor AreA is essential for chromatin remodelling in a eukaryotic bidirectional promoter.

Authors:  M I Muro-Pastor; R Gonzalez; J Strauss; F Narendja; C Scazzocchio
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

6.  Multiple layers of cooperativity regulate enhanceosome-responsive RNA polymerase II transcription complex assembly.

Authors:  K Ellwood; W Huang; R Johnson; M Carey
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

7.  Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin.

Authors:  F Carrier; P T Georgel; P Pourquier; M Blake; H U Kontny; M J Antinore; M Gariboldi; T G Myers; J N Weinstein; Y Pommier; A J Fornace
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

Review 8.  Chromatin modification and disease.

Authors:  C A Johnson
Journal:  J Med Genet       Date:  2000-12       Impact factor: 6.318

9.  p300-mediated acetylation facilitates the transfer of histone H2A-H2B dimers from nucleosomes to a histone chaperone.

Authors:  T Ito; T Ikehara; T Nakagawa; W L Kraus; M Muramatsu
Journal:  Genes Dev       Date:  2000-08-01       Impact factor: 11.361

10.  Antagonistic remodelling by Swi-Snf and Tup1-Ssn6 of an extensive chromatin region forms the background for FLO1 gene regulation.

Authors:  A B Fleming; S Pennings
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.